Presented at the 7th International Conference on Head and Neck Cancer, San Francisco, CA, July 19–23, 2008.
Transoral CO2 laser treatment for Tis–T3 glottic cancer: The University of Brescia experience on 595 patients†
Article first published online: 9 NOV 2009
Copyright © 2009 Wiley Periodicals, Inc.
Head & Neck
Volume 32, Issue 8, pages 977–983, August 2010
How to Cite
Peretti, G., Piazza, C., Cocco, D., De Benedetto, L., Del Bon, F., Redaelli De Zinis, L. O. and Nicolai, P. (2010), Transoral CO2 laser treatment for Tis–T3 glottic cancer: The University of Brescia experience on 595 patients. Head Neck, 32: 977–983. doi: 10.1002/hed.21278
- Issue published online: 13 JUL 2010
- Article first published online: 9 NOV 2009
- Manuscript Accepted: 27 AUG 2009
- glottic carcinoma;
- transoral surgery;
- carbon dioxide laser;
- oncologic outcomes
Transoral CO2 laser surgery has been accepted as a valuable therapeutic option for glottic cancer.
This was a retrospective analysis of 595 patients. Five-year overall and disease-specific survivals, local control with laser, locoregional, regional control, and organ preservation rates were calculated. The impact of different variables was calculated by univariate analysis.
Overall, disease-specific and disease-free survivals, local control with laser, locoregional, regional control, and organ preservation rates were 87.5%, 99%, 81.3%, 92.7%, 98.9%, 98.2%, and 97.1%, respectively. Univariate analysis showed a significant impact of pT category on local control with laser, organ preservation, locoregional and regional control, of endoscopic re-treatment for positive deep surgical margins on local control with laser and organ preservation, and recurrence after endoscopic re-treatment on local control with laser and organ preservation.
This series confirms the good oncologic outcomes of endoscopic laser surgery for Tis, T1, and selected T2 and T3 glottic tumors. © 2009 Wiley Periodicals, Inc. Head Neck, 2010